CHAPTER 1. INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3. MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4. MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Growing pressure for declination of drug discovery and development costs
4.1.2. Growing number of drug discovery activities
4.1.5. Increasing R&D expenditure in pharmaceuticals
4.2. Market Restraints & Challenges
4.2.1. Issues with existing technologies
4.2.2. Development of silico-based prediction models
4.3. Market Opportunities
4.3.1. Growth in CRO (Contract Research Organization) industry
CHAPTER 5. GLOBAL PROTEIN BINDING ASSAY MARKET – BY TECHNOLOGY
5.1. Equilibrium Dialysis
5.2. Ultrafiltration
5.2. Ultracentrifugation
5.4. Others
CHAPTER 6. GLOBAL PROTEIN BINDING ASSAY MARKET – BY END USER
6.1. Pharmaceutical & Biotechnology Companies
6.2. CROs
6.3. Others
CHAPTER 7. GLOBAL PROTEIN BINDING ASSAY MARKET - BY GEOGRAPHY
7.1. Introduction
7.2. North America
7.2.1. U.S.
7.2.2. Canada
7.2.3. Mexico
7.2.4. Costa Rica
7.3. South America
7.3.1. Brazil
7.3.2. Argentina
7.3.3. Chile
7.3.4. Columbia
7.3.5. Others
7.4. Europe
7.4.1. U.K.
7.4.2. Germany
7.4.3. France
7.4.4. Italy
7.4.5. Spain
7.4.6. Russia
7.4.7. Netherlands
7.4.8. Switzerland
7.4.9. Poland
7.4.10. Others
7.5. APAC
7.5.1. China
7.5.2. Japan
7.5.3. India
7.5.4. South Korea
7.5.5. Australia & New Zealand
7.5.6. Malaysia
7.5.7. Singapore
7.5.8. Others
7.6. Middle East & Africa
7.6.1. UAE
7.6.2. Saudi Arabia
7.6.3. Iran
7.6.4. Iraq
7.6.5. Qatar
7.6.6. South Africa
7.6.7. Algeria
7.6.8. Morocco
7.6.9. Nigeria
7.6.10. Egypt
7.6.11. Others
CHAPTER 8. GLOBAL PROTEIN BINDING ASSAY MARKET - COMPANY
PROFILES
8.1. Bio-Rad Laboratories, Inc.
8.2. Merck KGaA
8.3. Cell Signaling Technology Inc.
8.4. General Electric Company
8.5. PerkinElmer Inc.
8.6. Abcam PLC
8.7. Thermo Fisher Scientific
8.8. Johnson & Johnson
8.9. Absorption Systems
8.10. Danaher Corporation
8.11. 3B Pharmaceutical GmbH
8.12. Biotium
8.13. Admecell Inc.
8.14. HT Dialysis LLC
8.15. QIAGEN
CHAPTER 9. GLOBAL PROTEIN BINDING ASSAY MARKET - COMPETITIVE
LANDSCAPE
9.1. Market Share Analysis
9.2. Strategies adopted by top companies
9.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 10. MARKET INSIGHTS
10.1. Industry Experts Insights
10.2. Analysts Opinions
10.3. Investment Opportunities
CHAPTER 11. APPENDIX
11.1. List of Tables
11.2. List of Figures
